Timothyr Wright News Today

/PRNewswire/ -- PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named...

26.08.2022 - The Cato T. Laurencin Regenerative Engineering Founders’ Award Promotes Advancement of Scientific Leadership and Research in the Field of Regenerative Engineering MARIETTA, Ga., Aug. 26, 2022 (GLOBE NEWSWIRE) - MiMedx Group, Inc. (Nasdaq: MDXG) ... Seite 1

MiMedx Group, Inc. (NASDAQ:MDXG – Get Rating) CEO Timothy R. Wright sold 112,000 shares of the company’s stock in a transaction that occurred on Thursday, June 9th. The stock was sold at an average price of $3.75, for a total value of $420,000.00. Following the completion of the sale, the chief executive officer now owns […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

First Quarter Net Sales of $58.9 Million Reflects Double-Digit Revenue Increase for the Third Straight Quarter in the Company's Continuing Portfolio of...

Shareholders Urged to Support MIMEDX Board MARIETTA, Ga., April 29, 2022 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the...

Wall Street analysts expect that MiMedx Group, Inc. (NASDAQ:MDXG – Get Rating) will report $54.10 million in sales for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for MiMedx Group’s earnings, with estimates ranging from $54.00 million to $54.20 million. MiMedx Group posted sales of $59.97 million in the same quarter last […]

MiMedx Group (NASDAQ:MDXG – Get Rating) issued its quarterly earnings results on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.04, MarketWatch Earnings reports. During the same period last year, the firm earned ($0.17) EPS. MiMedx Group updated its FY 2022 guidance to EPS. […]

Company to Share Probability Values from its Knee Osteoarthritis (KOA) Study; Analyses Conducted Support Confidence in Initiation of Confirmatory Phase 3...

Urges Shareholders to Vote the WHITE Proxy Card “FOR ALL” Four of MIMEDX’s Director Nominees – Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner Entirely Reconstituted Board and New Management Team Positioned Company for Long-Term Sustainable Growth; Stock Price Appreciation of 237% Since Timothy Wright Selected as CEO Virtual Annual Meeting to Be Held on May 27, 2021 MARIETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (�...